Versions Compared
Key
- This line was added.
- This line was removed.
- Formatting was changed.
Documents
| Ballot Document | |
| 2022SEP Ballot Reconciliation | |
Reconciliation redline: 20220729 Consultant Pharmacist Consult Note - with revision marks.pdf Reconciliation clean: 20220729 Consultant Pharmacist Consult Note - clean.pdf | |
| Prepublication final review | |
Final review redline: 20230226 Pharmacist Consultation Note pre-pub review+edits.docx Ready for publication: 20230226 Pharmacist Consultation Note for publication.docx |
Timeline
| Sept 2022 Ballot | Jan 2023 Ballot | |
|---|---|---|
| Notice of Intent to Ballot (NIB) | July 3 - done | Nov 1, 2022 |
| Final Content to Pharmacy WG | Aug 1 - done | Nov 28, 2022 |
| Final Content deadline | Aug 7 - done | Dec 6, 2022 |
| Ballot open | Aug 12 | Dec 11, 2022 |
| concurrent NCPDP comment-only ballot | ||
| Ballot close | Sept 11 - done | Jan 11, 2023 |
| Reconciliation | Dec 1 - done | |
| Pre-pub review | Feb 26 - done | |
| Submit for publication | pendingSept 12 ... in progress |
Project change to FHIR IG
On the June 2nd Consultant Pharmacist Interoperability call, the group discussed the FHIR IG v Guidance Document issue and decided to stay with a guidance document. FHIR IG work has been suspended.
During the May 2022 WGM Pharmacy WG Thursday Q2 session, there was considerable discussion on changing the final output to a FHIR IG. This would retain all of the current content - C-CDA and FHIR. The primary driver was a FHIR IG is more likely to be visible to FHIR developers - they know to search for FHIR IGs and probably would not consider searching for guidance documents.
Changing to creating a FHIR IG requires:
- change request for PSS
- request for approval to create a FHIR IG
- request for HL7 GitHub repository for development of the IG
- transfer of existing content to the IG
- establishing the software environment to produce the IG
FHIR IG Process steps/status
| task | date / status | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
PSS change request to create FHIR IG | Draft submitted to project team, Pharmacy and StrucDoc co-chairs for review. Pharmacy WG approved change |
| ||||||||
Request to develop FHIR IG | Draft submitted to project team and pharmacy co-chairs Pharmacy WG approved IG request | Pharmacist Consultation Note IG | ||||||||
Request GitHub repository | Jira ticket created. Needs FHIR IG approval before repository can be created done |
| ||||||||
Set up development environment | started installing components - FSH, SUSHI, FHIR IG publisher, more - development environment complete | |||||||||
FSH (FHIR ShortHand) course | course materials released | |||||||||
Initial port of Guidance Document to FHIR IG |
Project Development
Project Proposal | Project Scope Statement | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||||||||||||||
DescriptionThis project will create a joint HL7/NCPDP Consultant Pharmacist Consult Note guidance document. The guidance document will address the use of either CCDA Consult Note or FHIR Consultation Note Profile. This will be a guidance document, not an implementation guide or FHIR profile. | DescriptionThis project will create a joint HL7/NCPDP Consultant Pharmacist Consult Note guidance document. The guidance document will address the use of either C-CDA Consult Note or C-CDA on FHIR Consultation Note Profile. This will be a guidance document, not an implementation guide or FHIR profile. Previously, NCPDP published the NCPDP Consultant Pharmacy Consult Note guidance document to address how C-CDA Consult Note is to be used to address Consultant Pharmacy reporting requirements.. This project will update the NCPDP Consultant Pharmacy Consult Note guidance document as described above to address both the C-CDA Consultation Note and the C-CDA on FHIR Consultation Note Profile. The product of this project will be published as a joint NCPDP/HL7 document. Note: Initial review has not revealed any additional constraints or extensions on the FHIR Consultation Note Profile, thus allowing this project to just produce a guidance document. If constraints or extensions become necessary, then a FHIR profile will be developed and jointly published, following HL7 processes to revise a project. |
Project Calls
every other Monday at 1p EST / 10a PST / 1800 UTC
see the agenda/minute list below for the next session
Web session: https://zoom.us/j/3231998494
phone: 669-900-6833, meeting 3231998494#
voip/iOS/Android:
tel:+16699006833,,3231998494# US (San Jose CA)
Find your local number: https://us02web.zoom.us/u/kbxHfAjJot
| Children Display | ||||
|---|---|---|---|---|
|